The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
Open accessAbstract
which predominantly occurred in young males after the second dose, an ACIP meeting was rapidly convened to review reported cases of myocarditis and pericarditis and discuss the benefits and risks of mRNA COVID-19 vaccination in the United States. Myocarditis is an inflammation of the heart muscle; if it is accompanied by pericarditis, an inflammation of the thin tissue surrounding the heart (the pericardium), it is referred to as myopericarditis. Hereafter, myocarditis is used to refer to myocarditis, pericarditis, or myopericarditis. On June 23, 2021, after reviewing available evidence including that for risks of myocarditis, ACIP determined that the benefits of using mRNA COVID-19 vaccines under the FDA's EUA clearly outweigh the risks in all populations, including adolescents and young adults. The EUA has been modified to include information on myocarditis after receipt of mRNA COVID-19 vaccines. The EUA fact sheets should be provided before vaccination; in addition, CDC has developed patient and provider education materials about the possibility of myocarditis and symptoms of concern, to ensure prompt recognition and management of myocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, our study confirms findings of previ ously identified rare cases of myocarditis and pericarditis following first and second doses of mRNA vaccines [21 -23,34].”
From COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals (2024) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“In women aged 18–24, mRNA COVID-19 vaccination would prevent 1127 hospitalisations, 93 ICU admissions and 13 deaths, while causing 4–5 myocarditis cases. 25”
From Vaccine mandates for healthcare workers beyond COVID-19 (2023) · cites this paper as [25]
In the citing paper
“1 million mRNA COVID-19 vaccination doses would prevent 936 hospitalisations, 215 intensive care unit (ICU) admissions and 13 deaths, while simultaneously leading to 15–18 vaccine-associated myocarditis cases.”
From Vaccine mandates for healthcare workers beyond COVID-19 (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,325
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627
Self-citationPreliminary evidence on long COVID in children
Buonsenso, D., Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., Carfì, A., & Valentini, P. (2021) · Acta Paediatrica · doi:10.1111/apa.15870 · Cited by 508
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
Payne, A. B., Gilani, Z., Godfred‐Cato, S., Belay, E. D., Feldstein, L. R., Patel, M. M., Randolph, A. G., Newhams, M. M., Thomas, D., Magleby, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16420 · Cited by 395
Self-citationThe Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Baggs, J. M., Gee, J. M., Lewis, E. M., Fowler, G. L., Benson, P. J., Lieu, T. A., Naleway, A. L., Klein, N. P., Baxter, R. P., Belongia, E. A., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722h · Cited by 349
Self-citationThe effects of gender and age on occurrence of clinically suspected myocarditis in adulthood
Kytö, V., Sipilä, J., & Rautava, P. (2013) · Heart · doi:10.1136/heartjnl-2013-304449 · Cited by 124
Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016
Vasudeva, R., Bhatt, P. J., Lilje, C., Desai, P., Amponsah, J. K., Umscheid, J., Parmar, N. G., Bhatt, N. S., Adupa, R., Pagad, S., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.03.019 · Cited by 53
Cited by
Sorted by citations
Items 401–500 of 586
Recurrent MRI-documented myocarditis following Pfizer-BioNTech SARS-CoV-2 vaccination
Bucur, P., Smith, C., AlJaroudi, W., & Berman, A. E. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.06.024 · Cited by 2
Valencic, E., Naviglio, S., Ronfani, L., Abbracciavento, G., & Tommasini, A. (2023) · Acta Paediatrica · doi:10.1111/apa.16804 · Cited by 2
COVID Vaccine and Cardiovascular Risks: A Natural Language Analysis of Vaccine Adverse Event Reports
Zhao, Y., Ison, M. G., & Luo, Y. (2021) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669540 · Cited by 2
COVID-19 FAQs in Pediatric Cardiac Surgery: 2022 Perspective and Updates
Levy, E. R., Dearani, J. A., Blumenthal, J. A., Johnson, J. N., Overman, D. M., Stephens, E. H., & Chiotos, K. (2022) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/21501351221085966 · Cited by 2
What should be done to protect children from COVID-19 in the UK?
Brown, K., Pappachan, J., & McKee, M. (2022) · Archives of Disease in Childhood · doi:10.1136/archdischild-2022-323839 · Cited by 2
Myocarditis after COVID ‐19 mRNA vaccination in Australia
Varma, S. K., Horton, A., Taylor, A. L., Ditchfield, M. R., Hope, S. A., & Rao, S. J. (2022) · The Medical Journal of Australia · doi:10.5694/mja2.51657 · Cited by 2
Evaluation of some cardiac markers in relation to COVID-19 mRNA vaccine
AL-Eqabi, A., & Al-Azzawi, B. A. (2022) · Journal of Biomedicine and Biochemistry · doi:10.57238/jbb.2022.19395 · Cited by 2
One year follow up for case series of myocarditis following mRNA vaccination against SARS-CoV-2
Petersen, M. R., Budweg, J. B., & Matar, R. M. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100294 · Cited by 2
Cardiac Involvement in COVID-19: A Matter Close to the Heart, Beyond the Acute Illness
de Oliveira, G. M. M., & Pinto, F. J. (2023) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20230024 · Cited by 2
Garg, R., Hussain, M., & Friedrich, M. G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1186556 · Cited by 2
Demi̇r, R. (2023) · doi:10.5152/0114 · Cited by 2
Salman, M., Mallhi, T. H., Khan, Y. H., Mustafa, Z. U., Tanweer, A., Ikram, M., Hussain, K., Butt, M. H., Ramdas, N., Meyer, J. C., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-086877 · Cited by 4
Pharmacovigilance. Vaccins à ARNm contre le Covid-19 : le point sur les effets indésirables
Favre, V., Ekobena, P., Chtioui, H., Rothuizen, L. E., Livio, F., Genton, B., & Buclin, T. (2022) · JMIG · doi:10.53738/revmed.2022.18.767.190 · Cited by 2
A case of myopericarditis following administration of the Pfizer COVID-19 vaccine
Morton, Z., Green, D., & Grisham, M. (2022) · Archive of Clinical Cases · doi:10.22551/2022.34.0901.10195 · Cited by 2
Formanek, A., Wagner, T., Newrkla, S., & Kurz, H. (2022) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-022-00959-6 · Cited by 2
Novikov, M., Hasanpourghadi, M., Ambrose, R., Chekaoui, A., Newman, D., Giles‐Davis, W., Xiang, Z., Zhou, X., & Ertl, H. C. J. (2022) · SSRN Electronic Journal · doi:10.1101/2022.02.23.481620 · Cited by 1
Hu, M., Wong, H., Feng, Y., Lloyd, P. C., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., Mitra, M., et al. (2022) · medRxiv · doi:10.1101/2022.10.28.22281532 · Cited by 2
Low-Dose Interferon I and III-Based Nasal Sprays: A Good-Looking COVID-19 Vaccine Candidate?Preprint
Carp, T.-N., & Metoudi, M. (2022) · Preprints.org · doi:10.20944/preprints202212.0155.v2 · Cited by 1
Carp, T.-N., Metoudi, M., Brown, B., & Ojha, V. (2023) · Preprints.org · doi:10.20944/preprints202212.0155.v4 · Cited by 2
Hu, M., Shoaibi, A., Feng, Y., Lloyd, P. C., Wong, H., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., et al. (2023) · medRxiv · doi:10.1101/2023.10.13.23296903 · Cited by 2
Vacunación contra COVID-19 en niños
Aragón-Nogales, R., & Miranda-Novales, M. G. (2021) · Revista Mexicana de Pediatría · doi:10.35366/102187 · Cited by 2
Children Lagging with COVID-19 Vaccination
Noor, A., Bäcker, M., & Krilov, L. R. (2022) · Pediatric Annals · doi:10.3928/19382359-20220314-06 · Cited by 1
COVID-19 Vaccine-Induced Acute Perimyocarditis: A Case Report
Phogat, V., Nepal, S., Gadula, S. S. P., Wardeh, A. H., & Aiello, D. (2022) · Cureus · doi:10.7759/cureus.31554 · Cited by 1
Vaccine efficacy, safety, and regulatory controls
Hillery, A. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28934-7.00008-x · Cited by 1
A Series of Glomerular Diseases That Developed After COVID-19 Vaccination
Umezawa, Y., Suzuki, H., Hirose, H., Takahara, H., Tomita, S., & Suzuki, Y. (2025) · Cureus · doi:10.7759/cureus.81085 · Cited by 1
Loedy, N., Dorta, H. G., Abrams, S., Crèvecoeur, J., Morales, D. R., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., et al. (2025) · European Journal of Public Health · doi:10.1093/eurpub/ckaf135 · Cited by 1
Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough
Mishra, V. K., Ranjan, A., & Mishra, Y. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003212 · Cited by 1
Nazar, W., Romantowski, J., Nazar, G., Niedoszytko, M., & Daniłowicz‐Szymanowicz, L. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12023-w · Cited by 1
Siliste, R., Benea, S. N., Homentcovschi, C., Deaconu, T., Căruntu, C., & Săvulescu-Fiedler, I. (2026) · Life · doi:10.3390/life16020268 · Cited by 1
Pfeiffer, S., Rhee, M., Striplin, S. P., Urdaneta, V., Straus, W., Wang, X., Girard, B., Priddy, F. H., & Chalkias, S. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag139 · Cited by 1
Zhu, Z., & Su, X. (2026) · Medicine · doi:10.1097/md.0000000000050214 · Cited by 1
Documento de posición COVID-19 y corazón
Tajer, C. D., Kazelián, L. R., Pereiro, S. M., Gagliardi, J., D’Imperio, H., & Prat, M. R. (2021) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v89.s6 · Cited by 1
Hazards of Vaccinating the Way Out of Covid-19 Pandemic
Tiwari, P. N., & Kushwaha, A. S. (2022) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_428_22 · Cited by 1
The First Ethiopian Case Report of Post-COVID-19 Vaccine Associated Guillain-Barre Syndrome
Demissie, Z., Tesfaye, E., Bitew, A., Worku, A., & Haile, T. (2022) · doi:10.56558/journal.ejmscr.1001041 · Cited by 1
COVID-19 and arrhythmias - is there a relationship?
Ахмедов, В. А., Livzan, M. A., & Gaus, O. V. (2022) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2022-3-3-17-24 · Cited by 1
Approaches to pretransplant vaccination
Kates, O. S. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000994 · Cited by 1
Pericardite aguda após vacina contra COVID-19
Lopes, N., Henriques, M. A., & Gonçalves, M. J. (2022) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v38i6.13368 · Cited by 1
Montgomery, J. R. (2023) · Federal Practitioner · doi:10.12788/fp.0354 · Cited by 1
Adverse events following immunization with COVID-19 vaccines
Sajodin, S., & Alfin, R. (2023) · Gaceta Médica de Caracas · doi:10.47307/gmc.2023.131.s1.7 · Cited by 1
Yen, C.-W., Lee, J., Chang, Y., Lee, E., Wu, C., & Chang, Y.-J. (2023) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2023.01.005 · Cited by 1
Miller, E. R., Moro, P. L., Shimabukuro, T. T., Carlock, G., Davis, S. N., Freeborn, E. M., Roberts, A. L., Gee, J. M., Taylor, A. W., Gallego, R., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.05.054 · Cited by 1
Self-citationCharacteristics of Teenagers Presenting with Chest Pain after COVID-19 mRNA Vaccination
Park, C. H., Yang, J., Lee, H. S., Kim, T. H., & Eun, L. Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134421 · Cited by 1
Stress Echocardiography Post-COVID-19
D’Andrea, A., Sabatella, F., & Picano, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-31062-1_39 · Cited by 1
Suspected Myocarditis after mRNA COVID-19 Vaccination among South Korean Adolescents
Kim, M. J., Kim, J. H., Jun, H. O., Kim, K. M., Jeung, M. S., & Park, J. S. (2023) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0043-1777091 · Cited by 1
Feltes, G. I., Sánchez, V., David, E. P., Moreno-Hurtrez, J. L., Delgado, J. F., & Nuñez-Gil, I. J. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11090259 · Cited by 1
Kim, W. D., Cha, M. J., Kim, S., Kim, D., Kwak, J.-J., Cho, S. W., Doh, J., Kwon, S. U., Namgung, J., Lee, S. Y., et al. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0354 · Cited by 1
Arrhythmias in Children with Acute Respiratory Viral Infections: Prevalence and Causes
Israfilova, S. K., Kruchina, T. K., & Новик, Г. А. (2024) · Вопросы современной педиатрии · doi:10.15690/vsp.v23i4.2782 · Cited by 1
Doyon-Plourde, P., Farley, R., Krishnan, R., Tunis, M. C., Wallace, M. M., & Zafack, J. G. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126406 · Cited by 1
Self-citationDesign and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study
Truong, D. T., Harty, B. J., Bainton, J., Baker, A., Bradford, T. T., Cai, B., Coleman, J., de Luise, C., Dionne, A., Friedman, K. G., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.11.008 · Cited by 1
Lababidi, G. H., Lababidi, H., Bitar, F. F., & Arabi, M. T. (2024) · Cardiology in the Young · doi:10.1017/s1047951124026118 · Cited by 1
Akther, S., Samiha, F., Sony, S. A., Haque, M. A., Hasnat, M. A., Islam, S. M. S., Ahmed, S., & Abdullah-Al-Shoeb, M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1435930 · Cited by 2
COVID-19 mRNA Vaccination Mimicking Heart Attack in a Healthy 56-Year-Old Physician
Xinias, I., Mavroudi, A., Theodorou, G.-T., & Roilidis, I. (2022) · Infectious Disease Reports · doi:10.3390/idr14010011 · Cited by 2
SARS-CoV-2-fertőzés és annak megelőzése gyermekkori krónikus szisztémás autoimmun betegségekben
Constantin, T., Kulcsár, A., Krivácsy, P., Mészner, Z., Ponyi, A., Tóth, A., Ónozó, B., & Szekanecz, Z. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32448 · Cited by 1
Zaveri, S., Kest, H., Bhavin, S., DeBruin, W., & Colletti, M. (2022) · Cureus · doi:10.7759/cureus.24665 · Cited by 1
La myocardite et la péricardite après un vaccin à ARN messager contre la COVID-19
Goldman, R. D. (2022) · Canadian Family Physician · doi:10.46747/cfp.680119
Castro, F., & Ullauri-Solórzano, V. E. (2022) · Metro Ciencia · doi:10.47464/metrociencia/vol30/suppl1/2022/26-29 · Cited by 1
Guidelines for immunization of children following multisystem inflammatory syndrome in children
Ludwikowska, K. M., Okarska‐Napierała, M., Matkowska‐Kocjan, A., Jackowska, T., Wysocki, J., Kuchar, E. P., Peregud-Pogorzelski, J. W., & Szenborn, L. (2022) · Pediatria Polska · doi:10.5114/polp.2022.116576 · Cited by 1
Sdogkos, E., Sideri, A., Kasmeridis, C., Konstantinou, T., & Vogiatzis, I. (2022) · Medical Archives · doi:10.5455/medarh.2022.76.215-220 · Cited by 1
Schwartz, B. N., Harahsheh, A. S., Krishnan, A. N., & Martin, G. R. (2022) · American Journal of Perinatology · doi:10.1055/s-0042-1757238 · Cited by 1
Oshima, Y., Nozue, T., Takagi, S., Asada, T., Gamou, T., Iwaki, T., & Michishita, I. (2022) · International Heart Journal · doi:10.1536/ihj.22-344 · Cited by 1
Bellamoli, M., Vanoost, J., Gonçalves, M. D. V. C., Ammirati, E., & Honton, B. (2022) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001419 · Cited by 1
Myocarditis Related-COVID-19 mRNA Vaccination: A Narrative Review
Gushaendri, I., Shafia, F., Hairunisa, N., Yousif, E. A., & Amalia, H. (2023) · Al- Anbar Medical Journal · doi:10.33091/amj.2023.139728.1106
Furukawa, T., Ishikawa, S., & Nakajima, M. (2023) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.39.106 · Cited by 1
Brown, K. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.10.007 · Cited by 1
Cruz, J., Duret, A., Harwood, R., Fraser, L., Jones, C. B., Ward, J., Whittaker, E., Kenny, S. E., & Viner, R. (2021) · medRxiv · doi:10.1101/2021.12.06.21267339 · Cited by 1
Vaccination of elite athletes against SARS-CoV-2 and broader implications for public health policyPreprint
Sheehan, J. (2022) · doi:10.31219/osf.io/z64gx · Cited by 1
Acute cardiac side effects after COVID-19 mRNA vaccination, a case seriesPreprint
Freise, N. F., Kivel, M., Grebe, O. C., Meyer, C. G., Wafaisade, B., Peiper, M., Zeus, T., Schmidt, J., Neuwahl, J., Jazmati, D., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1157175/v2 · Cited by 1
Dove, M. L., Slesnick, T. C., Oster, M. E., Hashemi, S., Patel, T., & Wilson, H. C. (2022) · medRxiv · doi:10.1101/2022.09.01.22279517 · Cited by 1
Self-citationLow-Dose Interferon I and Iii-Based Nasal Sprays: A Good-Looking Covid-19 Vaccine Candidate?Preprint
Carp, T.-N., & Metoudi, M. (2022) · Preprints.org · doi:10.20944/preprints202212.0155.v1
Myocarditis and Pericarditis Following the SARS-CoV-2 Infection and COVID-19 VaccinationPreprint
Afshar, Z. M., Liang, J. J., Habib, M. A., Moghadam, M. A. T., Babazadeh, A., Ramzani, E., Hosseinzadeh, R., Hashemi, E., Sio, T. T. W., Allahgholipour, A., et al. (2023) · Preprints.org · doi:10.20944/preprints202302.0085.v1 · Cited by 1
Low-Dose Interferon I and III-Based Nasal Sprays: A Good-Looking COVID-19 Vaccine Candidate?Preprint
Carp, T.-N., Metoudi, M., Brown, B., & Ojha, V. (2023) · Preprints.org · doi:10.20944/preprints202212.0155.v3
Forsdyke, D. R. (2023) · doi:10.32388/mlp1tn · Cited by 1
Forsdyke, D. R. (2023) · Qeios · doi:10.32388/mlp1tn.3 · Cited by 1
„Coronavirus disease 2019 (COVID‑19)“ im Kindes- und Jugendalter
Zepp, F., & Knuf, M. (2021) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-021-01326-2 · Cited by 8
Миокардит след имунизация с първа доза информационна РНК ваксина срещу COVID-19
Стоименов, Б., & Pancheva, R. (2021) · Редки болести и лекарства сираци · doi:10.36865/2021.v12i2.141
Safety Assessment of BNT162b2 Vaccine in Adolescents Aged 12-15 YearsPreprint
Patel, J., Bhavsar, B., Parikh, S., & Ladani, N. (2021) · medRxiv · doi:10.1101/2021.11.06.21266016
Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment
Masago, K., & Fujita, S. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.10.002
Narrative Review: Addressing Covid-19 Vaccine Concerns in Special and Vulnerable Populations
Owusu, K. A., Effendi, M. K., Bastin, M. L. T., Tirmizi, S., Lat, I., & Ammar, M. A. (2022) · Hospital Pharmacy · doi:10.1177/00185787211066463
Myocarditis Post mRNA COVID-19 Vaccine- To Fear or Not to Fear?
Ahmed, A., Lodhi, A., & Siddiqui, M. S. (2021) · Liaquat National Journal of Primary Care · doi:10.37184/lnjpc.2707-3521.3.18
Evidencia sobre las vacunas para COVID-19 en niñas, niños y adolescentes
Risso, A., Chiaborelli, M., & Ciapponi, A. (2022) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v25i1.6997
Effectiveness and Safety of COVID-19 Vaccine
Nishi, J. (2021) · TRENDS IN THE SCIENCES · doi:10.5363/tits.26.10_18
Overview of pediatric myocarditis and pericarditis
Castillo, A. V., & Ivsic, T. (2022) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2022.101526 · Cited by 1
"Pfizer/Biontech Post Vaccine Acute St-Elevation Myocardial Infarction: A Case"
Coşkun, A. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.40.006495
Perimyocarditis after COVID-19 mRNA Vaccine: The Role of Cardiac Magnetic Resonance ImagingPreprint
Kumar, A. K., Harmon, E., Yesilyaprak, A., Agrawal, A., Manna, S., Schoenhagen, P., & Klein, A. L. (2021) · doi:10.22541/au.163397990.07079537/v1
Louten, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90565-7.00014-9
Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus
Iwanicka, J., Iwanicki, T., Kaczmarczyk, M., & Mazur, W. (2022) · Polish Journal of Microbiology · doi:10.33073/pjm-2022-022
Abdalla, M. N., Bordini, C. A. A., Wilbert, D. D., & Menezes-Rodrigues, F. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i8.31473
Vaccination for COVID-19 in Patients with Heart Failure with Reduced Ejection Fraction
Schonhofen, I. S., Fernandes, A. M. S., Macêdo, T. S., Silveira, B., Costa, B., & Feitosa, M. D. (2022) · doi:10.51941/amcr.2022.2103
Irure, J., Belmar, L., Fernández‐Fresnedo, G., González-López, E., Castro‐Hernández, C., Rodrigo-Calabia, E., Heras-Vicario, M., Ruiz, J. C., & López‐Hoyos, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4106837
Myopericarditis and COVID-19 Vaccination
Rao, M. (2022) · Journal of Virology and Viral Diseases · doi:10.54289/jvvd2200110
mRNA COVID-19 Vaccine Related Myocarditis and Pericarditis in the Australian Capital Territory
O'Driscoll, R., Fang, J., Srinivasan, J. R., & Wilson, S. E. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.06.355
Acute myocarditis following coronavirus disease 2019 vaccination in a 14‐year‐old Japanese boy
Ishida, T., Suzuki, K., Koyama, S., Shinohara, T., & Saitoh, S. (2022) · Pediatrics International · doi:10.1111/ped.15256
SARS-COV-2 and Other mRNA Vaccines
Jackson, N. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_6
Chiu, D. C. S. (2022) · Quality of life in Asia · doi:10.1007/978-981-19-3061-4_7
Booster Dose for Tackling Emerging Variant of SARS-CoV-2
Kumar, A., Kumar, A., Banerjee, R., & Das, N. (2022) · Indo Global Journal of Pharmaceutical Sciences · doi:10.35652/igjps.2022.12028
Kim, E., Kim, H. J., & Han, D. H. (2022) · Research Square · doi:10.21203/rs.3.rs-2040782/v1
COVID-19 vaccine insights: The news beyond the headlines
Kiley (2022) · The Journal of Family Practice · doi:10.12788/jfp.0486
Safety and status report of SARS-CoV-2 vaccination in patients with Wilson's disease.Preprint
Han, H., Zhao, D., Fang, X., Yang, W., Wang, M., Liu, Q., Wang, L., Ji, Z., Zhang, J., Hou, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2152063/v1
Han, H., Zhao, D., Fang, X., Yang, W., Wang, M., Liu, Q., Wang, L., Ji, Z., Zhang, J., Hou, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2152063/v2
Condiciones especiales en enfermedades reumáticas
Ortiz, B. O. A. (2021) · CID - Centro de Investigación y Desarrollo eBooks · doi:10.37811/cl_w798
Metadata
- Authors
- Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., Scobie, H. M., Moulia, D., Markowitz, L. E., Wharton, M., McNally, V. V., Romero, J. R., Talbot, H. K., Lee, G. M., Daley, M. F., & Oliver, S. E.
- Affiliations
- Kaiser Permanente (US)
- Corresponding author
- Gargano, Julia W.
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2021-07-09
- Volume
- 70
- Issue
- 27
- Pages
- 977-982
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC8312754
- OpenAlex
- W3178327314
- Cited by
- 587
- References
- 7
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 66 · 2023: 138 · 2022: 239 · 2021: 92
- FWCI
- 89.67
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- U.S. Department of Health and Human Services
- Minnesota Department of Health
- Council of State and Territorial Epidemiologists
- Kaiser Permanente
- Vanderbilt University
- Emory University
- George Washington University
- Nationwide Children's Hospital
- University of Washington
- Johns Hopkins University (COVID-19)
- Drexel University
- American Pharmacists Association
- Saint Louis University
- Public Health Agency of Canada
- Marshfield Clinic Research Institute
- Kaiser Permanente Washington Health Research Institute
- Northwell Health
- Public Health Agency
- National Institutes of Health (COVID-19)
- Centers for Disease Control and Prevention
- School of Medicine, Vanderbilt University
- University of California, Los Angeles
- College of Medicine, Drexel University
- Wake Forest School of Medicine
- Research Institute, Nationwide Children's Hospital
- Biomedical Advanced Research and Development Authority
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 mRNA vaccine, myocarditis, pericarditis, myopericarditis, vaccine safety, Advisory Committee on Immunization Practices, emergency use authorization, adolescents and young adults, patient and provider education
- MeSH terms
- COVID-19, COVID-19 Vaccines, mRNA Vaccines, Adolescent, Adult, Centers for Disease Control and Prevention, U.S., Child, Female, Humans, Immunization, Male, Myocarditis, United States, Vaccines, Synthetic, Adverse Drug Reaction Reporting Systems, Practice Guidelines as Topic, Advisory Committees, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
